This study reveals that the presence of liver metastases is a poor prognostic factor but does not affect the improvements in both PFS and OS brought by adding PD‐1 blockade to chemotherapy in ESCC patients. The gene discussed is PDCD1; the disease is esophageal squamous cell carcinoma.